Your session is about to expire
← Back to Search
12-16 hour nutrition for Bone Marrow Transplant
N/A
Waitlist Available
Led By Christopher Dandoy
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients >/= 12 months of age undergoing HSCT and receiving a myeloablative preparative regimen
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 21 days
Awards & highlights
Study Summary
This study is evaluating whether the timing of meals may impact sleep, metabolism, and overall health in hospitalized children.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 21 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~21 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Duration of wake episodes
Number of wake episodes
Secondary outcome measures
Cortisol levels
Glucose levels
Hypertension
+4 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CasesExperimental Treatment1 Intervention
Patients randomized to the cases group will receive their nutrition over a period of 12-16 hours, with minimum 8 hours of fasting and maximum 12 hours of fasting. All patients will receive 100% of their daily nutrition.
Group II: ControlsActive Control1 Intervention
Patients randomized to the control group will receive the current standard of care (24-hour continuous nutrition). All patients will receive 100% of their daily nutrition.
Find a Location
Who is running the clinical trial?
Children's Hospital Medical Center, CincinnatiLead Sponsor
814 Previous Clinical Trials
6,531,560 Total Patients Enrolled
Christopher DandoyPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What outcomes are researchers hoping to achieve with this experiment?
"This experiment, which will last 21 days, seeks to observe the duration of wakefulness in participants. Additionally, weekly triglyceride levels, changes in weight at day +7, +14 and +21 from day 0 as well as 3 times a week morning cortisol levels are being measured as secondary outcomes."
Answered by AI
Is enrollment open for this experiment?
"This clinical trial, initially publicized on May 19th 2020 and last updated in October 14 2022, is not actively seeking participants. However, 45 other trials are currently recruiting patients for their studies."
Answered by AI
Share this study with friends
Copy Link
Messenger